Alto Neuroscience: PAX-D Study Published in The Lancet Psychiatry
– Compelling PAX-D results guided Alto’s acquisition of ALTO-207, designed to induce rapid antidepressant effects while mitigating dose-limiting adverse events of pramipexole – – Alto...